Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
The post Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength appeared first on Business News.
Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
